Results 11 to 20 of about 48,572 (243)

Early-Onset Isolated Bilateral Pheochromocytoma As a Major Clinical Manifestation of von-Hippel Lindau Syndrome Type 2C

open access: yesJournal of Pediatric Research, 2018
Pheochromocytoma is a rare disease that is characterized by the increased production and secretion of catecholamines from the adrenal medulla. The disease is autosomal dominant, and frequently sporadic and unilateral. Pheochromocytoma, which is diagnosed
Sezer Acar   +9 more
doaj   +2 more sources

From Childhood Migraine Headache to Pheochromocytoma [PDF]

open access: yesCase Reports in Endocrinology, 2014
Pheochromocytoma may have multiple clinical manifestations including paroxysmal hypertension, tachycardia, sweating, nausea, and headache (Phillips et al., 2002). Migraine has some of the manifestations seen with pheochromocytoma.
Y. M. Hazimeh   +3 more
doaj   +2 more sources

Preoperative Metyrosine Administration for Bilateral Pheochromocytomas Following Pheochromocytoma Crisis: A Case Report. [PDF]

open access: yesIJU Case Rep
ABSTRACT Introduction Pheochromocytoma crisis complicated by catecholamine‐induced cardiomyopathy is a life‐threatening condition requiring careful preoperative management. Although metyrosine has recently been approved in Japan for the perioperative management of pheochromocytoma, clinical experience remains limited.
Demizu N   +9 more
europepmc   +2 more sources

Comparison of pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy [PDF]

open access: yes, 2019
Importance Large studies investigating long-term outcomes of patients with bilateral pheochromocytomas treated with either total or cortical-sparing adrenalectomies are needed to inform clinical management.Objective To determine the association of ...
Eng, Charis   +2 more
core   +2 more sources

Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. [PDF]

open access: yes, 1996
Inherited pheochromocytomas are often part of familial syndromes, especially multiple endocrine neoplasia type 2 (MEN 2), retinal cerebellar hemangioblastomatosis [von Hippel-Lindau (vHL) disease] or neurofibromatosis type 1.
Crossey, P.A.   +7 more
core   +1 more source

Pheochromocytoma [PDF]

open access: yesAnesthesiology, 1978
Pheochromocytoma, a relatively rare (<0.05% of hypertensives), catecholamine‐secreting tumor, is almost always lethal unless recognized and appropriately treated. Clinical and biochemical manifestations are mainly caused by excess circulating catecholamines and hypertension.
William M, Manger, Ray W, Gifford
openaire   +2 more sources

A Case of Multiple Organ Failure (MOF) Caused by an Adrenal Pheochromocytoma that Ruptured Spontaneously [PDF]

open access: yes, 2007
We report a case of an adrenal pheochromocytoma that ruptured spontaneously and caused multiple organ failure (MOF). Spontaneous rupture of pheochromocytoma is extremely rare, but it can be lethal because of dramatic changes in the circulation. A 44-year-
中山, 淳   +5 more
core   +1 more source

Clinicoradiological manifestations of paraganglioma syndromes associated with succinyl dehydrogenase enzyme mutation. [PDF]

open access: yes, 2011
BACKGROUND: Paragangliomas are rare tumours derived from the autonomic nervous system that have increasingly been recognised to have a genetic predisposition.
Hodgson, S   +11 more
core   +2 more sources

Immunological Features of Neuroendocrine Neoplasms and Adrenal Tumors. [PDF]

open access: yesCancer Med
ABSTRACT Neuroendocrine neoplasms, which occur throughout the human body, as well as adrenocortical carcinoma and pheochromocytoma, which originate in the adrenal gland, are primarily classified as rare malignancies. Immunotherapy, including immune checkpoint inhibitors (ICIs), is generally not incorporated into the standard care protocols for these ...
Ohmoto A, Takahashi S, Kitano S.
europepmc   +2 more sources

Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia

open access: yesNeuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objectives Acute cerebral ischemia is characterized by several pathological processes evolving during time, which contribute to the final tissue damage. Secondary processes, such as prolonged inflammatory response, impaired mitochondrial function and oxidative stress, are responsible for the progression of brain injury to the peri‐infarct area,
Fioravante Capone   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy